Ftse Mib
32.669,30
-2,80%
DAX
18.002,02
-1,43%
S&P 500
5.422,52
-0,21%
NASDAQ
17.633,80
-0,19%
Bitcoin
65.864,96
-1,34%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Abraxis Bioscience Inc. (MM) (ABII) Abraxis Bioscience Inc. (MM) (ABII) Notizie

ABII

Abraxis Bioscience Inc. (MM) (ABII)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABII
DataOraFonteTitoloSimboloCompagnia
15/10/201019:03Edgar (US Regulatory)(25-NSE)NASDAQ:ABIIAbraxis Bioscience Inc. (MM)
13/10/201022:30Business WireCelgene and Abraxis Announce Shareholder Vote in Favor of MergerNASDAQ:ABIIAbraxis Bioscience Inc. (MM)
12/10/201013:01Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ABIIAbraxis Bioscience Inc. (MM)
06/10/201012:03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:ABIIAbraxis Bioscience Inc. (MM)
14/09/201023:24Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)NASDAQ:ABIIAbraxis Bioscience Inc. (MM)
10/09/201023:24Edgar (US Regulatory)Proxy Soliciting Materials (revised) (PRER14A)NASDAQ:ABIIAbraxis Bioscience Inc. (MM)
05/08/201022:56Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ABIIAbraxis Bioscience Inc. (MM)
29/07/201017:29Dow Jones News2nd UPDATE: Celgene 2Q Profit Up 8.8%; Again Boosts 2010 ViewNASDAQ:ABIIAbraxis Bioscience Inc. (MM)
29/07/201015:45Dow Jones NewsUPDATE: Celgene 2Q Profit Up 8.8%; Again Increases 2010 ViewNASDAQ:ABIIAbraxis Bioscience Inc. (MM)
29/07/201013:28Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (PREM14A)NASDAQ:ABIIAbraxis Bioscience Inc. (MM)
29/07/201011:00Business WireAbraxis BioScience and Specialised Therapeutics Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New ZealandNASDAQ:ABIIAbraxis Bioscience Inc. (MM)
23/07/201015:00Business WireABRAXANE® Approved for Marketing in Japan for Breast CancerNASDAQ:ABIIAbraxis Bioscience Inc. (MM)
19/07/201022:16Business WireBull & Lifshitz, LLP Announces Investigation of the Acquisition of Abraxis BioScience Inc.NASDAQ:ABIIAbraxis Bioscience Inc. (MM)
12/07/201023:27Business WireFaruqi & Faruqi, LLP Investigates Potential Breaches of Fiduciary Duties by the Board of Abraxis BioSciences, Inc. - ABIINASDAQ:ABIIAbraxis Bioscience Inc. (MM)
09/07/201022:37Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ABIIAbraxis Bioscience Inc. (MM)
08/07/201023:30Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:ABIIAbraxis Bioscience Inc. (MM)
08/07/201001:41Business WireThe Law Office of Joseph Klein Investigates Possible Breach of Fiduciary Duty by the Board of Abraxis BioSciences Inc. - ABIINASDAQ:ABIIAbraxis Bioscience Inc. (MM)
02/07/201022:29Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ABIIAbraxis Bioscience Inc. (MM)
02/07/201017:36Business WireWolf Haldenstein Investigates Abraxis Bioscience, Inc. Proposed AcquisitionNASDAQ:ABIIAbraxis Bioscience Inc. (MM)
01/07/201023:24Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ABIIAbraxis Bioscience Inc. (MM)
01/07/201003:30Business WireLaw Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Abraxis BioScience, Inc.NASDAQ:ABIIAbraxis Bioscience Inc. (MM)
01/07/201002:05Business WireRobbins Umeda LLP Announces an Investigation of the Acquisition of Abraxis BioScience Inc. by Celgene CorporationNASDAQ:ABIIAbraxis Bioscience Inc. (MM)
01/07/201000:16Business WireFinkelstein Thompson LLP Announces Investigation of Abraxis Bioscience Inc.NASDAQ:ABIIAbraxis Bioscience Inc. (MM)
30/06/201022:30Business WireRyan & Maniskas, LLP Announces Investigation of Abraxis BioScience, Inc.NASDAQ:ABIIAbraxis Bioscience Inc. (MM)
30/06/201021:57Dow Jones News3rd UPDATE:Celgene Buy Of Abraxis Expands Cancer Treatment PushNASDAQ:ABIIAbraxis Bioscience Inc. (MM)
30/06/201021:30Dow Jones NewsAbraxis Deal Value Depends On CVRs; CVRs Seen UndervaluedNASDAQ:ABIIAbraxis Bioscience Inc. (MM)
30/06/201020:54Business WireTripp Levy PLLC Investigates Buyout of Abraxis BioSciencesNASDAQ:ABIIAbraxis Bioscience Inc. (MM)
30/06/201019:14Dow Jones News2nd UPDATE:Celgene Buy Of Abraxis Expands Cancer Treatment PushNASDAQ:ABIIAbraxis Bioscience Inc. (MM)
30/06/201019:01Business WireKendall Law Group Investigates Abraxis BioScience Inc. Merger for ShareholdersNASDAQ:ABIIAbraxis Bioscience Inc. (MM)
30/06/201019:00Business WireGoldfarb Branham Law Firm LLP Investigating Potentially Unfair Buyout of AbraxisNASDAQ:ABIIAbraxis Bioscience Inc. (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABII

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
BAMI
Banco BPM
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
G
Generali
BIT
NEXI
Nexi S.p.A
BIT
TIT
Telecom Italia
BIT
PST
Poste Italiane S.p.a
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network